VERSATILE CANINE INFLUENZA VIRUS VACCINE COMPOSITION

WIPO Patent Application WO/2016/186259

A1

The present invention relates to a versatile canine influenza virus vaccine composition using the HA2 helical domain of a hemagglutinin protein, which is an influenza surface protein, and to a pharmaceutical composition for preventing or treating canine influenza virus infectious diseases. The polypeptide represented by SEQ ID NO: 3 and the polypeptide expressed by residues 379 to 474 of SEQ ID NO: 1 of the present invention can be mass-produced in E. coli, effectively produce neutralizing antibodies to various canine influenza virus subtypes, and boost an immune induction effect of the existing canine influenza vaccine through combined administration, and thus the polypeptides can be widely utilized as versatile vaccines for influenza virus subtypes and new influenza virus variants.

WO/1992/012739	DEPOT FORMULATIONS
JP2017206510	VASCULAR DISRUPTION AGENT AND USE THEREOF
JP7071332	Adeno-associated virus virions with mutant capsids and how to use them

JEONG DAE GWIN (KR)
SONG DAE SUB (KR)
KIM JEONG KIE (KR)

PCT/KR2015/009617

November 24, 2016

September 14, 2015

Click for automatic bibliography generation  

KOREA RES INST BIOSCIENCE & BIOTECHNOLOGY (KR)

A61K38/16; A61K39/12; A61K39/39; A61K48/00

WO2015006384A1

2015-01-15

KR20130130326A	2013-12-02
KR100850545B1	2008-08-05
US20120014972A1	2012-01-19

WANG ET AL.: "Vaccination with A Synthetic Peptide from the Influenza Virus Hemagglutinin provides Protection against Distinct Viral Subtypes", PNAS, vol. 107, no. 44, 2010, pages 18979 - 18984, XP002675044

KIM, SOON WOONG (KR)
김순웅 (KR)

View/Download PDF      PDF Help

Previous Patent: EXPANDABLE SCREEN TYPE PORTABLE TERMINAL HAVING MULTIPLE SCREENS

Next Patent: VERSATILE INFLUENZA VIRUS VACCINE COMPOSITION